Sunday November 22 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Santen Incorporated

Santen Inc. is responsible for the development and commercialization of eye care pharmaceuticals in the U.S. It also serves as the international headquarters for Santen's business in Europe, with responsibility for research and development, international regulatory affairs, manufacturing, sales, marketing, and distribution.


Contact Details:
555 Gateway Drive
Napa
CA
94558
United States of America
Tel:
Fax:707 254 1769
Email:
WWW:

www.santeninc.com/




Loading...

Recent Publications by Santen Incorporated:

Cyclosporin A eye drops inhibit fibrosis and inflammatory cell infiltration in murine type I allergic conjunctivitis without affecting the early-phase reaction.
PURPOSE: To understand the mechanisms of action of cyclosporin A eye drops...
11th November, 2009
Research and Development Center, Santen Pharmaceutical Co., Ltd., 8916-16 Curr Eye Res. 2009 Jun;34(6):426-37.
Transient receptor potential vanilloid 1 agonists as candidates for anti-inflammatory and immunomodulatory agents.
We recently demonstrated that SA13353...
3rd November, 2009
Research and Development Center, Santen Pharmaceutical Co., Ltd., 8916-16 Eur J Pharmacol. 2009 Oct 28.
DOI Direct Link
Ocular hypotensive effects of anti-glaucoma agents in mice.
PURPOSE: To evaluate the ocular hypotensive effects induced by topical...
28th October, 2009
Research and Development Center, Santen Pharmaceutical Co. Ltd., Nara, J Ocul Pharmacol Ther. 2009 Oct;25(5):401-8.
DOI Direct Link
Cyclosporine A eye drops inhibit the early-phase reaction in a type-I allergic conjunctivitis model in mice.
PURPOSE: The effects of cyclosporine A eye drops on the early-phase...
22nd October, 2009
Research and Development Center, Santen Pharmaceutical Co. Ltd., J Ocul Pharmacol Ther. 2009 Aug;25(4):321-8.
DOI Direct Link
Disposition and metabolism of a novel prostanoid antiglaucoma medication, tafluprost, following ocular administration to rats.
The disposition and metabolism of tafluprost, an ester prodrug of the...
20th October, 2009
Non-clinical Research Group, Research and Development Center, Santen Drug Metab Dispos. 2009 Aug;37(8):1622-34. Epub 2009 May 28.
DOI Direct Link

View more Santen Incorporated research publications.

BioNews Results for Santen Incorporated:

CEO of Napa-Based Santen Inc. Joins Glaucoma Research Foundation Board
Pharma Live:  Nov 5 2009 6:26PM Matching: santen
Santen CEO Adrienne Graves Joins Board Of Glaucoma Research Foundation
Medical News Today:  Nov 4 2009 6:16AM Matching: santen
Medical News: Santen CEO Adrienne Graves Joins Board Of Glaucoma Research Foundation
Medical News Today:  Nov 3 2009 3:12PM Matching: santen
Medical News: Santen CEO Adrienne Graves Joins Board Of Glaucoma Research Foundation
Medical News Today:  Nov 3 2009 3:10PM Matching: santen
CBI Announces the Agenda for Their West Coast Forum on Clinical Supply Chain Management
PR Newswire via Yahoo!:  Sep 11 2009 12:22PM Matching: santen
Promote your company here: BioNewsCast - Press Release Distribution

View more Santen Incorporated news.

Santen Incorporated Clinical Trials:

Pharmacodynamics of Tafluprost 0.0015% Eye Drops: a Comparison Between the Preserved and Unpreserved Formulation

Santen Incorporated Patents:

US Patent No.Title
6221846 Ophthalmic drug compositions
6488938 Polylactic acid scleral plug
6492369 Therapeutic agents for drug dependence
6492370 Urea derivatives and pharmaceutical compositions thereof
6534499 N-substituted-N'-substituted urea derivatives and the use thereof as TNF-.alpha. production inhibitory agents

View more Santen Incorporated patents.

BioPortfolio Ltd provides targeted e-mail address lists for the life science sector - we can enable you to contact around 47 individuals from Santen Incorporated using this service.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 878 times since April 2007, the link to the organisation's website has been followed 146 times

Recent Search Terms used to find this page: santen | Cyclosporin A eye nonclinical | Santen Incorporated | saflutan merck concentration | TAFLUPROST US PATENTS | santen eye drops | Santen pharmaceutical Regulatory Affairs 2009 | santen business information | .

Search for more companies in Napa

Search for more companies in CA



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Santen Incorporated

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.